Companies / Santa Cruz Biotechnology / Ribosomal Protein L13 (SS-09)
Santa Cruz Biotechnology

Ribosomal Protein L13 (SS-09) | Santa Cruz Biotechnology

mouse monoclonal IgG2a; Ribosomal Protein L13 Antibody (SS-09) is an IgG2a κ mouse monoclonal Ribosomal Protein L13 antibody (also designated Ribosomal Protein L13 antibody) that detects the Ribosomal Protein L13 protein of mouse, rat and human origin by WB, IP, IF and ELISA. Ribosomal Protein L13 Antibody (SS-09) is available as the non-conjugated anti-Ribosomal Protein L13 antibody. Ribosomes, the organelles that catalyze protein synthesis, are composed of a small subunit (40S) and a large subunit (60S) that consist of over 80 distinct ribosomal proteins. Mammalian ribosomal proteins are encoded by multigene families that contain processed pseudogenes and one functional intron-containing gene within their coding regions. Ribosomal Protein L13, also known as RPL13 or BBC1 (breast basic conserved protein 1), is a 211 amino acid protein that is a component of the 60S subunit. Localized to the cytoplasm and expressed ubiquitously, Ribosomal Protein L13 belongs to the L13E family of ribosomal proteins and functions in protein synthesis. In addition, the gene encoding Ribosomal Protein L13 is expressed at high levels in benign breast lesions. Like most ribosomal proteins, Ribosomal Protein L13 exists as multiple processed pseudogenes that are scattered throughout the genome. Due to alternative splicing events and/or alternative polyadenylation, various isoforms exist for Ribosomal Protein L13.

Reviews


No reviews yet

ABOUT THE COMPANY

Santa Cruz Biotechnology is a world leader in the development of products for the biomedical research market. Over the past 30+ years, the Company has focused on the ongoing development of research antibodies, siRNA and CRISPR Gene editing tools, biochemicals, labware and more recently has expanded into animal health care products. Santa Cruz Biotechnology has the highest commitment to quality and customer service.